OTC Labeling Adopted By FDA In Forced Switch Would Violate Regs Comments Say
This article was originally published in The Tan Sheet
Executive Summary
FDA could not adopt a drug's approved OTC label from another country as acceptable U.S. OTC labeling without violating its own regulations, according to the American Association of Physicians & Surgeons and Competitive Enterprise Institute
You may also be interested in...
Rx Label Use Permissible Even If FDA Finds Drug Is Safe OTC – Attorney
A drug sponsor may create and use alternative labeling saying it requires prescription distribution for a medicine even if FDA has determined the drug does not need to be limited to the Rx arena, according to attorney Andrew Krulwich of the Washington, D.C.-based law firm Wiley, Rein & Fielding
FDA-Initiated OTC Switches Could Be Based On Foreign Data – McClellan
FDA may rely on a drug's foreign OTC marketing experience to determine whether an Rx product should be switched OTC in the U.S. without sponsor consent, Commissioner Mark McClellan, MD/PhD, said at a Manhattan Institute roundtable discussion for buyside analysts May 16
Claritin, Alavert, Advil Allergy Sinus Head Major OTC Approvals In 2002
Antihistamines accounted for the most prominent OTC approvals in 2002, with Schering-Plough Healthcare Products' Claritin franchise and Wyeth Consumer Healthcare's Alavert and Advil Allergy Sinus all receiving the FDA go-ahead during the year